Redwood City, United States
Codexis, Inc., founded in 2002, is a U.S.-based biotechnology company revolutionizing therapeutic manufacturing with its innovative platforms. As stated in its slogan, “Transforming Therapeutic Manufacturing,” the company leverages proprietary technology to outperform traditional methods, opening new possibilities for therapeutic development.
Positioned at the intersection of Biotechnology and Sustainability, Codexis has established itself as not just a solutions provider but a long-term partner in the therapeutic field. The company's consistent track record is underscored by its commitment to advancing beyond conventional boundaries and driving progress in complex therapeutic manufacturing.
In terms of financial traction, the company's recent $40.00M Post Ipo Debt investment on 01 February 2024 from Innovatus Capital Partners signals robust investor confidence in its business model. This capital injection is poised to further its technology and market leadership.
BAO PHARMA